Interpretation of the pharmacoeconomical analysis in the context of rational choice of medicines

Cover Page

Cite item

Full Text

Abstract

The results of a study on the use of pharmacoeconomic analysis to justify the rational choice of drug therapy and costs of the program activities for the prevention and treatment of diseases are presented. A comparative analysis of the cost of treatment of liposomal and the traditional forms of doxorubicin was conducted. Justified costs (in terms of drug provision) for realization of the program of prevention and treatment of diseases related to iodine deficiency in children in the Republic of Karachay-Cherkessia (KChR) for 2010—2015, based on the use of «default values» of expenses, received in the result of pharmacoeconomic analysis and prognosis of the disease.

About the authors

E E Loskutova

Peoples' Friendship University of Russia

Email: loskutova@med.rudn.ru
Department of management and economics in pharmacy

T V Pak

Peoples' Friendship University of Russia

Email: vantv@list.ru
Department of management and economics in pharmacy

A M-A Ebzeeva

Peoples' Friendship University of Russia

Email: ebzeeva_a@mail.ru
Department of management and economics in pharmacy

A I Smirnov

Peoples' Friendship University of Russia

Email: 7210345@mail.ru
Department of management and economics in pharmacy

A A Teodorovich

Peoples' Friendship University of Russia

Email: aualenushka@mail.ru
Department of management and economics in pharmacy

References


Copyright (c) 2013 Лоскутова Е.Е., Пак Т.В., Эбзеева А.М., Смирнов А.И., Теодорович А.А.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies